Evidence map›Paper›PMID 38791117›Full record

ArticleInternational journal of molecular sciences2024

Inhibition of Shikimate Kinase from Methicillin-Resistant

Lluvia Rios-Soto, Alicia Hernández-Campos, David Tovar-Escobar, Rafael Castillo, Erick Sierra-Campos, Mónica Valdez-Solana, Alfredo Téllez-Valencia, Claudia Avitia-Domínguez

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Active components ofFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lluvia Rios-SotoFacultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango, Av. Universidad y Fanny, Anitúa S/N, Durango 34000, Mexico.
Alicia Hernández-CamposDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, México City 04510, Mexico.ORCID 0000-0003-4609-6581
David Tovar-EscobarDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, México City 04510, Mexico.ORCID 0009-0008-7256-1559
Rafael CastilloDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, México City 04510, Mexico.ORCID 0000-0003-4466-2340
Erick Sierra-CamposFacultad de Ciencias Químicas, Universidad Juárez del Estado de Durango, Av. Artículo 123 S/N Fracc. Filadelfia, Gómez Palacio 35010, Mexico.ORCID 0000-0001-8622-4045
Mónica Valdez-SolanaFacultad de Ciencias Químicas, Universidad Juárez del Estado de Durango, Av. Artículo 123 S/N Fracc. Filadelfia, Gómez Palacio 35010, Mexico.ORCID 0000-0002-8665-7761
Alfredo Téllez-ValenciaFacultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango, Av. Universidad y Fanny, Anitúa S/N, Durango 34000, Mexico.ORCID 0000-0001-7629-4111
Claudia Avitia-DomínguezFacultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango, Av. Universidad y Fanny, Anitúa S/N, Durango 34000, Mexico.

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías 322074Consejo Nacional de Humanidades, Ciencias y Tecnologías 80093
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is one of the biggest threats in modern times. It was estimated that in 2019, 1.27 million deaths occurred around the globe due to AMR. Methicillin-resistant

Indexed as

BenzimidazolesMethicillin-Resistant Staphylococcus aureusMolecular Docking SimulationPhosphotransferases (Alcohol Group Acceptor)Anti-Bacterial AgentsBacterial ProteinsEnzyme InhibitorsHumansKineticsMicrobial Sensitivity TestsMolecular Dynamics SimulationAnti-Bacterial AgentsBacterial ProteinsBenzimidazolesEnzyme InhibitorsPhosphotransferases (Alcohol Group Acceptor)shikimate kinaseantimicrobial resistanceenzyme inhibitionmethicillin-resistant Staphylococcus aureusmolecular dynamicsshikimate kinaseshikimate pathway

Identifiers

PMID38791117
PMCPMC11121535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.